{
    "2019-07-03": [
        [
            {
                "time": "2018-01-02",
                "original_text": "Pfizer (PFE) Gains But Lags Market: What You Should Know",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Gains",
                        "Lags Market"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-03",
                "original_text": "Notable ETF Inflow Detected - VOO, BRK.B, PFE, DIS",
                "features": {
                    "keywords": [
                        "ETF Inflow",
                        "VOO",
                        "BRK.B",
                        "PFE",
                        "DIS"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "diversified"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-04",
                "original_text": "3 Big Stock Charts for Wednesday: CVS Health, Pfizer and Weyerhaeuser",
                "features": {
                    "keywords": [
                        "Stock Charts",
                        "CVS Health",
                        "Pfizer",
                        "Weyerhaeuser"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals",
                        "real estate"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-05",
                "original_text": "Biotech Braces for Busy Summer as 2019 M&A Volume Heats Up",
                "features": {
                    "keywords": [
                        "Biotech",
                        "M&A Volume",
                        "Busy Summer"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-06",
                "original_text": "Will the Pharma Space Witness More Mega-Merger Deals in 2H?",
                "features": {
                    "keywords": [
                        "Pharma Space",
                        "Mega-Merger Deals",
                        "2H"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-07",
                "original_text": "Sanofi a Top Ranked SAFE Dividend Stock With 3.9% Yield (SNY)",
                "features": {
                    "keywords": [
                        "Sanofi",
                        "SAFE Dividend Stock",
                        "3.9% Yield"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-08",
                "original_text": "Trump's Bully Pulpit Didnâ€™t Stop Drug-Price Hikes",
                "features": {
                    "keywords": [
                        "Trump",
                        "Bully Pulpit",
                        "Drug-Price Hikes"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}